BTG3 and adult-onset Still disease: Other studies reporting long-term efficacy of ANA in sJIA and AOSD patients had shown similar results when comparing adjunct therapy versus monotherapy in terms of survival analysis as well as clinical and laboratory response (Laskari et al., 2011, Vitale et al., 2019).